Health technology company Thorne HealthTech wrapped a downsized initial public offering Thursday, selling 7 million shares at $10 each, well below the $13 to $15 pricing range previously announced.
Shares of THRN debuted on the Nasdaq at $8.50.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| 52-week range | $0.00 - $0.00 |
|---|---|
| 50-day moving average | $9.33 |
| 200-day moving average | $5.84 |
| Wall St. target price | $7.00 |
| PE ratio | 26.1282 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $0.39 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Thorne Healthtech stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Thorne Healthtech's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Thorne Healthtech's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 26x. In other words, Thorne Healthtech shares trade at around 26x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
However, Thorne Healthtech's P/E ratio is best considered in relation to those of others within the packaged foods industry or those of similar companies.
Thorne Healthtech's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $20.2 million.
The EBITDA is a measure of a Thorne Healthtech's overall financial performance and is widely used to measure a its profitability.
To put Thorne Healthtech's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $258 million |
|---|---|
| Operating margin TTM | 5.42% |
| Gross profit TTM | $0 |
| Return on assets TTM | 3.7% |
| Return on equity TTM | 14.12% |
| Profit margin | 7.88% |
| Book value | $2.85 |
| Market Capitalization | $550.6 million |
TTM: trailing 12 months
We're not expecting Thorne Healthtech to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, Thorne Healthtech's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Thorne Healthtech's is 0.8163. This would suggest that Thorne Healthtech's shares are less volatile than average (for this exchange).
To put Thorne Healthtech's beta into context you can compare it against those of similar companies.
Thorne HealthTech, Inc. , a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions. The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to enhance and maintain their health. It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.